MESA, Ariz., Nov. 22, 2011 /PRNewswire/ -- Matthew Likens, president and CEO of Ulthera, Inc. a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology is scheduled to present at two upcoming healthcare conferences:
-- Tuesday, Nov. 29 at 2:10 p.m. EST
23rd Annual Piper Jaffray Healthcare Conference in New York City, Nov. 29-30, 2011
Location: The New York Palace Hotel, 455 Madison Avenue, New York 10022
-- Tuesday, Dec. 6 at 12:00 p.m. PT
6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference in San Francisco, Dec. 6, 2011
Location: St. Regis, 125 3rd Street, San Francisco 94103
Likens will present an overview of the company as well as its accomplishments to date and prospects for the future.
(Logo: http://photos.prnewswire.com/prnh/20111122/NY10856LOGO )
Ulthera®, Inc. is a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® the procedure enabled by the System is a non-invasive face and neck treatment to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ulthera.com.
SOURCE Ulthera, Inc.